Aspartate aminotransferase¿to¿platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitis Martine A.M.C. Baven-Pronk; Camiel J.M. Marijnissen; Maaike Biewenga; Albert F. Stättermayer; Maarten E. Tushuizen; Bart van Hoek;

An exploratory machine learning model for predicting advanced liver fibrosis in autoimmune hepatitis patients: A preliminary study Qinglin Wei; Wen Li; Shubei He; Hongbo Wu; Qiaoling Xie; Ying Peng; Xingyue Zhang;

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience Thanikan Sukaram; Soe Thiha Maung; Yuda Chongpison; Tassanan Jaihan; Chonlada Phathong; Roongruedee Chaiteerakij;